University Medical Center Goettingen
umg.euTotal trials
59
Active
22
Phase 3
1
Total enrollment
23,415
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| EHM implantation | — | — | — | — | — | 1 |
Next readouts
- 2027-12
Top conditions
- CMT (Charcot Marie Tooth Disease)4
- Oral Health Care3
- Acute Pancreatitis3
- CMT3
- CMT - Charcot-Marie-Tooth Disease3
- CMT1A3
- Heart Failure3
- Cortical Excitability2
Frequently asked questions about University Medical Center Goettingen
- How many clinical trials does University Medical Center Goettingen have on ClinicalTrials.gov?
- University Medical Center Goettingen is listed as the lead sponsor on 59 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Medical Center Goettingen's trials are in Phase 3?
- 1 of University Medical Center Goettingen's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University Medical Center Goettingen focus on?
- University Medical Center Goettingen's most-studied conditions on ClinicalTrials.gov are CMT (Charcot Marie Tooth Disease), Oral Health Care, Acute Pancreatitis, CMT, CMT - Charcot-Marie-Tooth Disease.
- When are University Medical Center Goettingen's next clinical trial readouts?
- University Medical Center Goettingen has 1 upcoming primary-completion readout tracked here; the soonest is “Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure”, expected around 2027-12.